J. Martin-Babau

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Nadia Harbeck, Priya Rastogi, Miguel Martín et al. · Annals of Oncology · 2021 · 378 citations · Full text

Medicine, Oncology, Pharmacology +16

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

Marion Thibaudin, Jean-David Fumet, Benoist Chibaudel et al. · Nature Medicine · 2023 · 108 citations · Full text

Medicine, Pharmacology, Immuno-oncology Pharmacotherapy +13

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.

François Ghiringhelli, Benoist Chibaudel, Jaafar Bennouna et al. · Journal of Clinical Oncology · 2020 · 42 citations

Medicine, Immunology, Oncology +17

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study

Juliette Palle, David Tougeron, Astrid Pozet et al. · Oncotarget · 2017 · 38 citations · Full text

Medicine, Molecular Medicine, Oncology +17